Fluorescent exendin-4 derivatives for pancreatic β-cell analysis.
Bioconjug Chem · 2014
Last updated 2026-05-28Researchers modified a GLP-1 drug called exendin-4 to create fluorescent versions that can bind to insulin-producing pancreatic beta cells. They tested over 25 compounds and found several that effectively attach to these cells, allowing them to be studied using lab techniques like flow cytometry and microscopy.
AI summary of the abstract below.
| Journal | Bioconjug Chem, 2014 |
|---|---|
| Citations | 35 |
| Relative citation ratio | 1.08 |
| NIH percentile | 53 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
The ability to reliably identify pancreatic β-cells would have far reaching implications for a greater understanding of β-cell biology, measurement of β-cell mass in diabetes, islet transplantation, and drug development. The glucagon-like peptide-1 receptor (GLP1R) is highly expressed on the surface of insulin producing pancreatic β-cells. Using systematic modifications of the GLP1R ligand, exendin-4, we screened over 25 compounds and identified a palette of fluorescent exendin-4 with high GLP1R binding affinity. We show considerable differences in affinity, as well as utility of the top candidates for flow cytometry and microscopy of β-cells. Some of the developed compounds should be particularly useful for basic and translational β-cell research.
Verbatim abstract via PubMed 24328216 ↗